Theseus Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q3 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Theseus Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q3 2021 to Q3 2023.
  • Theseus Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending September 30, 2023 was $4.65M, a 14.8% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $4.65M -$811K -14.8% Sep 30, 2023 10-Q 2023-11-17
Q2 2023 $4.85M -$805K -14.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.04M -$1.21M -19.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.23M -$568K -9.79% Dec 31, 2022 10-K 2023-03-09
Q3 2022 $5.47M -$337K -5.81% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $5.65M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $6.26M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $5.8M Dec 31, 2021 10-K 2022-03-10
Q3 2021 $5.8M Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.